Literature DB >> 25776030

Automatic quantification of lobular inflammation and hepatocyte ballooning in nonalcoholic fatty liver disease liver biopsies.

Scott Vanderbeck1, Joseph Bockhorst1, David Kleiner2, Richard Komorowski3, Naga Chalasani4, Samer Gawrieh5.   

Abstract

Automatic quantification of cardinal histologic features of nonalcoholic fatty liver disease (NAFLD) may reduce human variability and allow continuous rather than semiquantitative assessment of injury. We recently developed an automated classifier that can detect and quantify macrosteatosis with greater than or equal to 95% precision and recall (sensitivity). Here, we report our early results on the classifier's performance in detecting lobular inflammation and hepatocellular ballooning. Automatic quantification of lobular inflammation and ballooning was performed on digital images of hematoxylin and eosin-stained slides of liver biopsy samples from 59 individuals with normal liver histology and varying severity of NAFLD. Two expert hepatopathologists scored liver biopsies according the nonalcoholic steatohepatitis clinical research network scoring system and provided annotations of lobular inflammation and hepatocyte ballooning on the digital images. The classifier had precision and recall of 70% and 49% for lobular inflammation, and 91% and 54% for hepatocyte ballooning. In addition, the classifier had an area under the curve of 95% for lobular inflammation and 98% for hepatocyte ballooning. The Spearman rank correlation coefficient for comparison with pathologist grades was 45.2% for lobular inflammation and 46% for hepatocyte ballooning. Our novel observations demonstrate that automatic quantification of cardinal NAFLD histologic lesions is feasible and offer promise for further development of automatic quantification as a potential aid to pathologists evaluating NAFLD biopsies in clinical practice and clinical trials.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Digital image analysis; Fatty liver; Hepatocyte ballooning; Lobular inflammation; Machine learning; NAFLD activity score

Mesh:

Year:  2015        PMID: 25776030      PMCID: PMC8320703          DOI: 10.1016/j.humpath.2015.01.019

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  18 in total

1.  Effects of interventions on intra- and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology.

Authors:  Samer Gawrieh; Darly M Knoedler; Kia Saeian; James R Wallace; Richard A Komorowski
Journal:  Ann Diagn Pathol       Date:  2010-11-24       Impact factor: 2.090

2.  Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease.

Authors:  Ravi Juluri; Raj Vuppalanchi; John Olson; Aynur Unalp; Mark L Van Natta; Oscar W Cummings; James Tonascia; Naga Chalasani
Journal:  J Clin Gastroenterol       Date:  2011-01       Impact factor: 3.062

3.  Prevalence of fatty liver in children and adolescents.

Authors:  Jeffrey B Schwimmer; Reena Deutsch; Tanaz Kahen; Joel E Lavine; Christina Stanley; Cynthia Behling
Journal:  Pediatrics       Date:  2006-10       Impact factor: 7.124

4.  Automatic classification of white regions in liver biopsies by supervised machine learning.

Authors:  Scott Vanderbeck; Joseph Bockhorst; Richard Komorowski; David E Kleiner; Samer Gawrieh
Journal:  Hum Pathol       Date:  2013-11-26       Impact factor: 3.466

5.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

Authors:  C A Matteoni; Z M Younossi; T Gramlich; N Boparai; Y C Liu; A J McCullough
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

6.  Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.

Authors:  Jeffrey D Browning; Lidia S Szczepaniak; Robert Dobbins; Pamela Nuremberg; Jay D Horton; Jonathan C Cohen; Scott M Grundy; Helen H Hobbs
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

Review 7.  Pathology of nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-03-02       Impact factor: 46.802

8.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

9.  Endpoints and clinical trial design for nonalcoholic steatohepatitis.

Authors:  Arun J Sanyal; Elizabeth M Brunt; David E Kleiner; Kris V Kowdley; Naga Chalasani; Joel E Lavine; Vlad Ratziu; Arthur McCullough
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

10.  Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

Authors:  Jason M Hui; James G Kench; Shivakumar Chitturi; Archana Sud; Geoffrey C Farrell; Karen Byth; Pauline Hall; Mahbub Khan; Jacob George
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

View more
  6 in total

Review 1.  Therapeutic pipeline in nonalcoholic steatohepatitis.

Authors:  Raj Vuppalanchi; Mazen Noureddin; Naim Alkhouri; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-02-10       Impact factor: 46.802

Review 2.  Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research.

Authors:  Marcello Mancini; Paul Summers; Francesco Faita; Maurizia R Brunetto; Francesco Callea; Andrea De Nicola; Nicole Di Lascio; Fabio Farinati; Amalia Gastaldelli; Bruno Gridelli; Peppino Mirabelli; Emanuele Neri; Piero A Salvadori; Eleni Rebelos; Claudio Tiribelli; Luca Valenti; Marco Salvatore; Ferruccio Bonino
Journal:  World J Hepatol       Date:  2018-02-27

3.  Automated assessment of steatosis in murine fatty liver.

Authors:  Deepak Sethunath; Siripriya Morusu; Mihran Tuceryan; Oscar W Cummings; Hao Zhang; Xiao-Ming Yin; Scott Vanderbeck; Naga Chalasani; Samer Gawrieh
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240

4.  High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Roberta Forlano; Benjamin H Mullish; Nikolaos Giannakeas; James B Maurice; Napat Angkathunyakul; Josephine Lloyd; Alexandros T Tzallas; Markos Tsipouras; Michael Yee; Mark R Thursz; Robert D Goldin; Pinelopi Manousou
Journal:  Clin Gastroenterol Hepatol       Date:  2019-12-27       Impact factor: 11.382

5.  A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH.

Authors:  Amaro Taylor-Weiner; Harsha Pokkalla; Ling Han; Catherine Jia; Ryan Huss; Chuhan Chung; Hunter Elliott; Benjamin Glass; Kishalve Pethia; Oscar Carrasco-Zevallos; Chinmay Shukla; Urmila Khettry; Robert Najarian; Ross Taliano; G Mani Subramanian; Robert P Myers; Ilan Wapinski; Aditya Khosla; Murray Resnick; Michael C Montalto; Quentin M Anstee; Vincent Wai-Sun Wong; Michael Trauner; Eric J Lawitz; Stephen A Harrison; Takeshi Okanoue; Manuel Romero-Gomez; Zachary Goodman; Rohit Loomba; Andrew H Beck; Zobair M Younossi
Journal:  Hepatology       Date:  2021-06-24       Impact factor: 17.425

6.  Digital Pathology Enables Automated and Quantitative Assessment of Inflammatory Activity in Patients with Chronic Liver Disease.

Authors:  David Marti-Aguado; Matías Fernández-Patón; Clara Alfaro-Cervello; Claudia Mestre-Alagarda; Mónica Bauza; Ana Gallen-Peris; Víctor Merino; Salvador Benlloch; Judith Pérez-Rojas; Antonio Ferrández; Víctor Puglia; Marta Gimeno-Torres; Victoria Aguilera; Cristina Monton; Desamparados Escudero-García; Ángel Alberich-Bayarri; Miguel A Serra; Luis Marti-Bonmati
Journal:  Biomolecules       Date:  2021-12-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.